Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Galectin Therapeutics Inc |
4/11 | 3,470 USD
+3,58% |
+3,58% |
|
Galmed Pharmaceuticals Ltd |
8/10 | 3,620 USD
+4,69% |
+4,69% |
Genedrive Plc |
4/11 | 0,975 GBX
+2,63% |
+2,63% |
Genfit |
4/11 | 11,140 EUR
+0,54% |
+0,54% |
|
Genmab |
4/11 | 55,120 USD
-0,72% |
-0,72% |
|
Genoway |
4/11 | 1,915 EUR
-7,93% |
-7,93% |
|
Genprex Inc |
4/11 | 2,140 USD
-7,36% |
-7,36% |
|
GenSight Biologics S.A. |
4/11 | 0,069 EUR
-3,35% |
-3,35% |
|
Geovax Labs Inc |
4/11 | 0,168 USD
+2,38% |
+2,38% |
Geratherm Medical AG |
4/11 | 2,130 EUR
0,00% |
0,00% |
|
Geron Corp. |
4/11 | 1,080 USD
+16,13% |
+16,13% |
|
Gilead Sciences |
4/11 | 174,480 USD
+4,19% |
+4,19% |
|
Glaukos Corporation |
4/11 | 246,700 USD
+5,86% |
+5,86% |
|
Globus Medical Inc |
4/11 | 87,100 USD
+9,45% |
+9,45% |
|
GlucoTrack Inc |
4/11 | 0,400 USD
-12,59% |
-12,59% |
|
Gossamer Bio Inc |
4/11 | 9,950 USD
+7,22% |
+7,22% |
|
Greenwich LifeSciences Inc |
4/11 | 16,350 USD
+2,70% |
+2,70% |
Grifols SA |
4/11 | 11,225 EUR
-0,04% |
-0,04% |
|
Grifols SA |
29/10 | 7,240 EUR
-1,50% |
-1,50% |
|
Grifols SA |
4/11 | 8,610 USD
+0,58% |
+0,58% |
|
GSK Plc
|
4/11 | 51,150 USD
+5,03% |
+5,03% |
|
GSK Plc
|
4/11 | 1.890,000 GBX
+3,42% |
+3,42% |
|
GT Biopharma Inc |
4/11 | 4,840 USD
-8,16% |
-8,16% |
|
Guerbet SA |
4/11 | 6,260 EUR
-0,95% |
-0,95% |
|
Gunsynd plc |
4/11 | 0,675 GBX
0,00% |
0,00% |